Kazuto Shibuya

University of Toyama

Papers

2

Total Citations

16

H-Index

2

About

Kazuto Shibuya is a leading surgical oncologist whose research focuses on advancing minimally invasive pancreatic surgery, particularly for pancreatic cancer. His major contributions center on generating high-level evidence to establish the oncologic safety and efficacy of minimally invasive distal pancreatectomy (MIDP), including laparoscopic and robotic approaches. Shibuya is the principal investigator of the landmark JCOG2202 (LAPAN study), a multi-institutional randomized phase III trial comparing MIDP to open distal pancreatectomy—a study that directly addresses the critical gap in evidence regarding long-term oncologic outcomes. His work has garnered significant attention, with his most cited papers accumulating over 16 citations in the short time since their 2024 publication. Additionally, Shibuya leads the WRAP Study, a multicenter randomized controlled trial investigating the use of polyglycolic acid mesh and fibrin glue to prevent clinically relevant postoperative pancreatic fistula, the most common and serious complication after distal pancreatectomy. Through these rigorous trials, Shibuya is shaping the future standard of care for pancreatic surgery, providing the surgical community with essential data to guide clinical decision-making and improve patient outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
16
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical Oncology Group study JCOG2202 (LAPAN study)
9 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 66
🏛 Institutions: University of Toyama

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago